Pharmaceuticals, Biotechnology and Life Sciences
Spectrum Pharmaceuticals has submitted updated BLA to the USFDA, for Rolontis, based on two large pivotal randomized controlled studies that…
Tarveda Therapeutics said in a PR Friday that PEN-221 miniature drug conjugate allow for deep tumor penetration, while limiting plasma…
INDIANAPOLIS–(BUSINESS WIRE)–Business professionals are invited to join Apex Benefits and global pharmaceutical and health industry leaders for “A Prescription for…
Allergan said Thursday that the U.S. FDA approved its supplemental Biologics License Application (sBLA) for Botox for the treatment younger patients with lower limb spasticity, excluding spasticity caused by cerebral palsy (CP).
Syros’s SY-1425 plus Azacitidine testing data showed 62% composite complete response rate, with 82% of patients achieving or maintaining transfusion…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
Tilray has imported medical cannabis to USA and Canada in support of a new trieal, first-of-its-kind, which will test the…
Baxter reported that in third quarter it got net revenue of $2.85 billion, which increased 3% on a reported basis…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has granted…
Rocket Pharmaceuticals said that two critical validations for an FA gene therapy product are: 1) stem cell engraftment in the…